Full Text View
Tabular View
No Study Results Posted
Related Studies
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
This study has been completed.
Study NCT00001462   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Emphysema
Lung Diseases, Obstructive
Alpha 1-Antitrypsin Deficiency
Additional conditions recognized in this trial
Lung Diseases
Pulmonary Emphysema
More general conditions related to this trial
Connective Tissue Diseases
Pathologic Processes
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases
Additional drug interventions recognized in this trial
Alpha 1-Antitrypsin
Protein C Inhibitor
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Trypsin Inhibitors
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services